David Baron

David Baron is a Senior Professor at Western University of Health Sciences. His research integrates neuroscience, psychiatry, and genetics, focusing on the neuropharmacology of dopamine in substance use disorders, addiction, and comorbid mental health conditions. His recent work employs pharmacogenomic GWAS meta-analyses to link facial and emotional recognition systems to schizophrenia, depression, and anxiety, and explores GLP-1 agonist pathways in relation to suicidal ideation and substance use disorder. He has also published expert consensus statements on lifestyle interventions for major depressive disorder and clinical advisories on genetic testing for substance use disorder risk.